Couldn't have asked for a worse day to release the results. It also looks like we are going to need a webinar with Porf Miles Prince to convince the market of the significance of these resutls.
More than double the SOC duration... months duration beyond benchmark target... 40% ORR with now two complete responses.
ODD granted for all TCL cancer types with every chance of being granted a registrational study with accelerated approval as the end game. Wakey wakey Mr Market
Ann: Continued promising results in PTX-100 TCL trial, page-10
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $32.21M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 4.0¢ | 3.9¢ | $35.17K | 896.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 350000 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 163887 | 2 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| PTX (ASX) Chart |